September 28, 2016 10:10 PM ET


Company Overview of Neovacs S.A.

Executive Profile

Miguel Sieler

Chief Executive Officer and Director, Neovacs S.A.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 3 different industries.

See Board Relationships
As of Fiscal Year 2015


Mr. Miguel Sieler has been the Chief Executive Officer at Neovacs S.A. since October 17, 2013. Mr. Sieler has over 32 years experience in the chemical and pharmaceutical industry. Mr. Sieler served as Chairman and Chief Executive Officer of Bayer Group in France since 1998 until 2008. Mr. Sieler served in various senior positions at Bayer AG, Leverkusen, (Germany) from 1975 to 2008. He joined Bayer AG, Leverkusen, (Germany) in 1975 for an international career which started ...

Corporate Headquarters

3-5, Impasse Reille
Paris, Ile-de-France 75014


Phone: 33 1 53 10 93 00
Fax: 33 1 53 10 93 03

Board Members Memberships

Chief Executive Officer and Director
Director, Chairman of Remuneration & Appointments Committee and Member of Audit & Accounts Committee


Master's Degree
Eberhard Karls Universität Tübingen
Unknown/Other Education
Institut d'Etudes Politiques de Paris

Other Affiliations

Annual Compensation

Total Annual Compensation€229,366

Stocks Options

All Other Compensation€1,175

Total Compensation

Total Annual Cash Compensation€230,541
Total Short Term Compensation€229,365
Other Long Term Compensation€1,175
Total Calculated Compensation€230,541

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Neovacs S.A., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at